VEGFB and endometrial cancer: CM Holland and colleagues found that VEGF-B mRNA was significantly lower in endometrial cancer than benign endometrium, while the expression level of Ang2 mRNA in endometrial carcinoma was higher than that in benign endometrium, but there was no statistical significance.